Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ad free!Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ad free today!Spring offer! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

AstraZeneca
Pharmaceuticals
GSK
Pfizer
Sanofi
Novo Nordisk
Teva
Johnson and Johnson
Merck and Co
Topics

Advertisement

AstraZeneca

Share

Top Latest Popular

🐣 SPRING OFFER! Go ad free with NewsNow Essentials at just £2.99/m!

🐣 SPRING OFFER! Stay informed ad free with NewsNow Essentials at just £2.99 a month!

AstraZeneca (AZN) stock drops despite market gains: Important facts to note Zacks 21h

Zacks 21h

AstraZeneca stock down 7% in 3 months: Should you buy, sell or hold? Zacks 3d

Zacks 3d

The Zacks analyst blog highlights applied materials, GE, AstraZeneca, team and applied energetics Zacks 2d

Zacks 2d

Advertisement

Top stock reports for applied materials, GE & AstraZeneca Zacks 3d

Zacks 3d

Advertisement

FDA Truqap approval highlights AstraZeneca’s precision oncology and valuation gap Simply Wall St 5d

Simply Wall St 5d

AstraZeneca builds up oncology as it looks to 2030 Scrip Pharma Intelligence 7d

Scrip Pharma Intelligence 7d

Advertisement

Advertisement

Latest

In the last 8 hours

India could be on the radar for AstraZeneca’s oral GLP-1 drug: MD The Hindu Business Line 15:29

Earlier Today

Astrazeneca (AZN) Stock Drops Despite Market Gains: Important Facts to Note Zacks 00:20

Yesterday

Making change happen at HBA Cambridge’s Innovation Leadership Forum at Homerton College Cambridge Independent 18:22 Thu, 18 Jun

Celonis London PI Day - AstraZeneca and Arm reveal how process intelligence underpins AI success Diginomica 17:23 Thu, 18 Jun

Wednesday

The terrifying number of patients who have suffered Covid jab complications revealed, after NHS pharmacist left paralysed by vaccine takes his own life MailOnline 14:29 Wed, 17 Jun

The Zacks Analyst Blog Highlights Applied Materials, GE, AstraZeneca, Team and Applied Energetics Zacks 09:46 Wed, 17 Jun

Tuesday

Top Stock Reports for Applied Materials, GE & AstraZeneca Zacks 22:34 Tue, 16 Jun

FDA Accepts AstraZeneca's Filing for Expanded Use of Ultomiris Zacks 19:00 Tue, 16 Jun

AstraZeneca Stock Down 7% in 3 Months: Should You Buy, Sell or Hold? Zacks 16:17 Tue, 16 Jun

Monday

Ultomiris granted Priority Review in the US as treatment for adults with immunoglobulin A nephropathy WebWire 16:05 Mon, 15 Jun

Advertisement

Advertisement

Advertisement

About our AstraZeneca news

Latest news on AstraZeneca, an Anglo-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, with live updates on products and research.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Industry Sectors Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Shire Shire
- Takeda Takeda
- Teva Teva
- Valneva Valneva
- Zoetis Zoetis